Latest News about NVO
Recent news which mentions NVO
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
December 20, 2023
From Benzinga
These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond
December 20, 2023
From Motley Fool
Novo Nordisk Collaborates With India's Online Marketplace To Remove Unauthorized Wegovy Listings
December 19, 2023
Tickers
NVO
From Benzinga
3 Stocks With the Potential to Be 2024’s Company of the Year
December 18, 2023
From InvestorPlace
Obesity/Diabetes Drug Class GLP-1s' Cost-Saving Potential: Decoding Impact on Healthcare Spending
December 18, 2023
From Benzinga
Wegovy's Success Spurs Novo Nordisk Foundation's Philanthropic Initiative To Enhance Respiratory Disease Vaccines
December 18, 2023
Tickers
NVO
From Benzinga
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
December 18, 2023
From Motley Fool
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
From Benzinga
25% of Warren Buffett's Secret Portfolio Is Invested in These 3 ETFs. Here's Why They're Great Picks for 2024.
December 18, 2023
From Motley Fool
3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts
December 18, 2023
From Motley Fool
If You Had Invested $10,000 in Novo Nordisk in 2018, This Is How Much You Would Have Today
December 17, 2023
Tickers
NVO
From Motley Fool
Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here's Why That Makes Eli Lilly Stock an Even Better Buy.
December 16, 2023
From Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
December 15, 2023
From Benzinga
The New Magnificent 7: 7 Stocks Rising to Prominence
December 15, 2023
From InvestorPlace
Ozempic Isn't the Best Weight-Loss Treatment Anymore. Here's Why That Shouldn't Matter to Novo Nordisk Investors.
December 14, 2023
From Motley Fool
Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett
December 14, 2023
From InvestorPlace
From InvestorPlace
From Benzinga
Nvidia, Disney and Tesla are among 2023’s buzziest stocks. Can they continue to sizzle in 2024?
December 13, 2023
From MarketWatch
LifeMD’s stock soars 13% as company and Medifast to create weight-management program that includes GLP-1 drugs
December 13, 2023
From MarketWatch
Weight Loss Drugs' Trickle Down Effect - Insurer Restrictions Create Access Challenges For Diabetes Patients
December 12, 2023
From Benzinga
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?
December 12, 2023
From Motley Fool
Better Weight Loss Stock: Eli Lilly or Novo Nordisk?
December 12, 2023
From Motley Fool
Bernie Sanders To Take On Ozempic, Wegovy, Weight Loss Drugs: 'Could Be Helpful, But They're Not Going To Be Helpful If People Can't Afford Them'
December 08, 2023
From Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
December 08, 2023
Tickers
NVO
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
From Motley Fool
From Motley Fool
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.